Related Experiment Videos
Erythropoietic protoporphyria: hepatic cirrhosis
The British Journal of Dermatology
|March 1, 1978
Summary
Erythropoietic protoporphyria (EPP) can lead to severe liver disease, including fatal cirrhosis, even in young patients. Early detection of liver pathology in EPP is crucial for managing this rare condition.
Area of Science:
- Hepatology
- Genetics
- Biochemistry
Background:
- Erythropoietic protoporphyria (EPP) is a rare genetic disorder.
- EPP is characterized by the accumulation of porphyrins in red blood cells and plasma.
- Liver involvement in EPP can be severe and progressive.
Observation:
- This study observed liver pathology and function in 12 patients with EPP.
- Liver biopsies revealed mild fibrosis in some patients without abnormal liver function.
- One young patient (11 years old) died from hepatic cirrhosis and failure due to EPP.
Findings:
- Fatal liver disease occurred in 13 EPP patients, with a mean age of death of 38 years.
- The deceased patient had a high concentration of protoporphyrin in the liver (5.75% of total weight).
- Liver pathology in EPP is distinctive and warrants detailed description.
Implications:
- EPP poses a significant risk of fatal liver disease.
- Proactive monitoring for liver complications in EPP patients is essential.
- Understanding EPP liver pathology can guide clinical management and therapeutic strategies.